UNSPSC 51112703: Enloplatin

This classification denotes a platinum compound with the molecular formula C7H16N2O.C6H6O4.Pt, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C7HT2IO79H, chemically known as platinum, (1,1-cyclobutanedicarboxylato(2-))(tetrahydro-4h-pyran-4,4-dimethanamine-n,n)-, (sp-4-2)- but more generally known as enloplatin, which bears US NIH Compound Identifier 68737. European Medicines Agency schedules Enloplatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06536MIG.

UNSPSC 51112703 Enloplatin is a Commodity code covering pharmaceutical products procured by state and local health agencies. The single recent opportunity on record shows a state health authority gathering market intelligence on direct-to-manufacturer prescription fulfillment models rather than procuring the drug itself. The Texas Health and Human Services Commission issued a Request for Information (RFI) in early April 2026 seeking vendor capabilities for a Therapeutic Pharmacy Initiative program that would establish direct relationships between the state's pharmacy benefit program and pharmaceutical manufacturers, bypassing traditional pharmacy benefit managers and group purchasing organizations. The RFI solicits vendor experience with direct contracting for self-insured employers and health plans, negotiated net pricing models without rebates, and value-based or outcomes-based agreements. This is a preliminary market intelligence mechanism; no formal evaluation criteria, site visits, or binding timelines are specified, and no award values or budget ranges have been identified at this stage.

Texas HHS is the sole recent issuing body under this code in the available record. The RFI represents exploratory procurement focused on program design and contracting strategy rather than an immediate purchase of the commodity itself. Upon completion of the information-gathering phase, the state intends to develop detailed specifications and pricing models for subsequent formal solicitations. The current source supports no additional geographic spread or representative recent opportunities beyond the Texas RFI.